Available evidence suggests that although maternal smoking is demonstrably associated with reduced birth weight and perinatal loss,4 there is little to suggest that major malformations of the central nervous system are associated with the habit. This is relevant in the current debate on the efficacy of multivitamin supplements given Serum IgA concentration and hepatotoxicity in rheumatoid arthritis treated with azathioprine A selective IgA deficiency in rheumatoid arthritis may be associated with striking improvement of disease activity.' A selective IgA deficiency occurring with second line treatment is also associated with both improvement in disease and the development of drug toxicity.2 We therefore measured baseline IgA concentrations in patients with rheumatoid arthritis severe enough to require a variety of second line agents to determine whether a low IgA concentration before treatment predisposed to drug toxicity.
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Patients, methods, and results
Six groups of 15 patients with classic or definite rheumatoid arthritis (American Rheumatism Association criteria) were treated with penicillamine (125 mg/day increasing to 500 mg/day by the eighth week of treatment), sodium aurothiomalate (50 mg/week intramuscularly and 50 mg/month maintenance dose after a total of 1 g), azathioprine (1-5 mg/kg/day), sulillean baseline data (SEAI) iZn patienlts with low ( 150 IU/ml) and high 400 IUml) initial IgA concentrations 54 (2) 57 (7) 61 (3) phasalazine (1-5-3-0 g/day), clozic (300 mg/day), and hydroxychloroquine sulphate (200 mg twice daily) for 24 weeks. The only other drugs allowed were non-steroidal anti-inflammatory agents (usually enteric coated aspirin). Before treatment the mean C reactive protein concentration and erythrocyte sedimentation rate (both useful indicators of disease activity) and IgA concentration were comparable for all six treatment groups. The mean ages and the sex ratios of patients were also comparable. Patients with a low serum IgA concentration (-150 IU/ml) (10 women, one man) and those with a high serum IgA concentration ( -400 IU/ml) (six women, six men) were then compared (table) . Hepatotoxicity was detected by significant increases in serum aspartate transaminase, y-glutamyltransferase, and alkaline phosphatase activities (though the latter two may also reflect disease activity, being slightly raised in 20-250, of patients3); nephrotoxicity was detected by increases in plasma urea and creatinine concentrations.
There was no significant difference in the incidence of toxic side effects between patients with low and high IgA concentrations except in patients taking azathioprine. The four patients withdrawn from azathioprine treatment because of liver toxicity, however, had initial IgA concentrations ranging from 98 to 150 IU/ml, while the remaining 11 patients had initial IgA concentrations ranging from 210 to 600 IU/ml. The low baseline IgA concentrations varied little up to the onset of hepatotoxicity. In all four patients hepatotoxicity was detected by an approximately fourfold increase in y-glutamyltransferase activity, a threefold increase in serum aspartate transaminase activity, and a doubling of the alkaline phosphatase activity in the absence of a fall in the erythrocyte sedimentation rate or C reactive protein concentration. In one patient this occurred two weeks after the start of treatment with azathioprine, in two patients after four weeks of treatment, and in the remaining patient by the eighth week. All four patients reported low or no alcohol intake during the study period (high alcohol intake may cause a rise in y-glutamyltransferase activity).4 Nephrotoxicity was not seen in these patients.
Comment
Comparison of C reactive protein concentration and erythrocyte sedimentacion rate in patients with high initial IgA concentrations, low initial IgA Concentration, and low initial IgA concentration with subsequent hepatotoxicity showed that there was no significant difference in disease activity between these three groups. Furthermore, hepatotoxicity occurred only with azathioprine, and other drug toxicity did not seem to be associated with initial low serum IgA concentration.
We suggest that the apparent association between a low IgA concentration and the subsequent development of hepatotoxicity with azathioprine requires further clarification, but, at present, patients with a low IgA concentration starting treatment with azathioprine should be monitored particularly closely. 
